Bioelectronics Corp (BIEL)

[gimmee greenbacks]

Is it “ off label “ if RecoveryRX is applied for post op pain and edema and there is incidental “ wound healing “
BTW treating for post op edema is part and parcel of “ wound care “ isn’t it?
If that is the case then a strong case could be made that RecoveryRX is already explicitly cleared for “ wound care “ wouldn’t it?

An inquiry to the FDA for clarification of terms for purposes of proposed changes for product labeling may be warranted here imo.




BIEL